Tyrosine kinase inhibitors as potential sensitizers of adoptive T cell therapy for hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a high-incidence malignant tumor worldwide and lacks effective treatment options. Targeted drugs are the preferred recommendations for the systemic treatment of hepatocellular carcinoma. Immunotherapy is a breakthrough in the systemic treatment of malignant tumors,...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Linjun, Wang, Xiaoyan, Huang, Shuying, Chen, Yanwei, Zhang, Peng, Li, Liang, Cui, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014465/
https://www.ncbi.nlm.nih.gov/pubmed/36936932
http://dx.doi.org/10.3389/fimmu.2023.1046771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014465/
https://www.ncbi.nlm.nih.gov/pubmed/36936932
http://dx.doi.org/10.3389/fimmu.2023.1046771

Ejemplares similares